[Translated article] Drug dosing in obese critically ill patients, a literature review
Open Access
- 28 December 2024
- journal article
- review article
- Published by Elsevier in Farmacia Hospitalaria
- Vol. 49 (3) , T169-T178
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- A systematic review of therapeutic enoxaparin dosing in obesityJournal of Thrombosis and Thrombolysis, 2024
- Comprehensive guidance for antibiotic dosing in obese adults: 2022 updatePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023
- High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical VentilationObesity, 2020
- Obesity in the critically ill: a narrative reviewIntensive Care Medicine, 2019
- Dosing Antifungals in Obesity: a Literature ReviewCurrent Fungal Infection Reports, 2019
- Ertapenem for osteoarticular infections in obese patients: a pharmacokinetic study of plasma and bone concentrationsEuropean Journal of Clinical Pharmacology, 2018
- Safety and Effectiveness of Daptomycin Across a Hospitalized Obese Population: Results of a Multicenter Investigation in the Southeastern United StatesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Serum In Vivo and In Vitro Activity of Single Dose of Ertapenem in Surgical Obese Patients for Prevention of SSIsObesity Surgery, 2013
- The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantationEuropean Journal of Clinical Pharmacology, 2011
- Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patientsEuropean Journal of Clinical Pharmacology, 1983